RFM
EBS icon

Royal Fund Management’s Emergent Biosolutions EBS Stock Holding History

Royal Fund Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-38
Closed -$2K – 254
2020
Q1 		$2K Buy
+38
New +$2.19K ﹤0.01% 491

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royal Fund Management's EBS Position: Q2 2020 in Review

Royal Fund Management sold out of Emergent Biosolutions (EBS) in Q2 2020, closing a stake of 38 shares — an estimated $2K sold.

Royal Fund Management first reported a position in EBS in Q1 2020 and held it in 1 quarter. The position peaked at $2K in Q1 2020. 299 funds tracked by Wall St. Rank hold EBS as of Q2 2020.

  • Royal Fund Management reported no remaining Emergent Biosolutions position as of Q2 2020 after selling out during the quarter.
  • Royal Fund Management sold 38 Emergent Biosolutions shares in Q2 2020, an estimated $2K.
  • Royal Fund Management first reported a position in Emergent Biosolutions in Q1 2020 and held it in 1 quarter.
  • Royal Fund Management's Emergent Biosolutions position peaked at $2K in Q1 2020.
  • 299 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2020.

Based on Royal Fund Management's 13F filing for Q2 2020, filed 6 Aug 2020.